Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SALM
2326
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $1.75M | ﹤0.01% |
245,800
+26,300
| +12% | +$191K |
|
2327
Beasley Broadcasting Group
BBGI
$41.3M
| $1.74M | ﹤0.01% |
8,895
+3,550
| +66% | +$764K |
|
|
GPP
2328
DELISTED
Green Plains Partners LP
GPP
| $1.73M | ﹤0.01% |
92,381
-8,600
| -9% | -$167K |
|
|
IVC
2329
DELISTED
Invacare Corporation
IVC
| $1.72M | ﹤0.01% |
+130,600
| New | +$1.72M |
|
2330
Pembina Pipeline
PBA
$28.6B
| $1.72M | ﹤0.01% |
51,800
-388,906
| -88% | -$12.6M |
|
2331
Chemung Financial Corp
CHMG
$404M
| $1.72M | ﹤0.01% |
41,951
+2,851
| +7% | +$111K |
|
2332
Genco Shipping & Trading
GNK
$1.14B
| $1.71M | ﹤0.01% |
180,830
+21,700
| +14% | +$231K |
|
|
GVP
2333
DELISTED
GSE Systems, Inc.
GVP
| $1.71M | ﹤0.01% |
55,060
-10
| -0% | -$330 |
|
|
EDN
2334
Edenor
EDN
$1.01B
| $1.7M | ﹤0.01% |
53,400
+38,400
| +256% | +$1.27M |
|
2335
First Internet Bancorp
INBK
$255M
| $1.7M | ﹤0.01% |
60,615
-12,282
| -17% | -$342K |
|
2336
Cass Information Systems
CASS
$745M
| $1.69M | ﹤0.01% |
33,909
-29,436
| -46% | -$1.44M |
|
2337
SEACOR Marine Holdings
SMHI
$265M
| $1.68M | ﹤0.01% |
+82,675
| New | +$1.58M |
|
2338
AMC Entertainment Holdings
AMC
$2.28B
| $1.68M | ﹤0.01% |
7,370
-77,159
| -91% | -$20.7M |
|
|
SAUC
2339
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
| $1.67M | ﹤0.01% |
643,800
+415,560
| +182% | +$1.19M |
|
2340
Preformed Line Products
PLPC
$2.25B
| $1.67M | ﹤0.01% |
36,013
+7,913
| +28% | +$390K |
|
|
CTO
2341
CTO Realty Growth
CTO
$825M
| $1.66M | ﹤0.01% |
107,573
+51,355
| +91% | +$764K |
|
|
PPP
2342
DELISTED
Primero Mining Corp
PPP
| $1.66M | ﹤0.01% |
4,806,824
+1,670,099
| +53% | +$758K |
|
|
FRBK
2343
DELISTED
Republic First Bancorp Inc
FRBK
| $1.66M | ﹤0.01% |
179,412
-238,027
| -57% | -$2.12M |
|
2344
Corvus Pharmaceuticals
CRVS
$1.25B
| $1.66M | ﹤0.01% |
137,100
+79,300
| +137% | +$847K |
|
|
SMED
2345
DELISTED
Sharps Compliance Corp
SMED
| $1.65M | ﹤0.01% |
391,100
+1,800
| +0.5% | +$7.68K |
|
|
RC
2346
Ready Capital
RC
$304M
| $1.65M | ﹤0.01% |
111,300
+21,500
| +24% | +$317K |
|
|
PHLT
2347
DELISTED
Performant Healthcare Inc
PHLT
| $1.65M | ﹤0.01% |
791,100
+13,100
| +2% | +$29.5K |
|
2348
Scholastic
SCHL
$783M
| $1.65M | ﹤0.01% |
37,901
+29,301
| +341% | +$1.27M |
|
2349
Harte-Hanks
HHS
$31.6M
| $1.65M | ﹤0.01% |
160,250
+3,940
| +3% | +$49.7K |
|
2350
Magnite
MGNI
$3.53B
| $1.65M | ﹤0.01% |
321,300
+218,200
| +212% | +$1.2M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.